IFNK

IFNK‏‎ (Interferon kappa) is a protein that in humans is encoded by the IFNK gene. It is a member of the interferon family, which are proteins released by host cells in response to the presence of pathogens such as viruses, bacteria, parasites, and also tumor cells.

Function[edit | edit source]

IFNK is a type I interferon and is produced in response to viral infection. It plays a crucial role in the immune response by inducing the expression of antiviral proteins and enhancing the presentation of antigens to immune cells. This helps to inhibit viral replication and stimulate the immune system to clear the infection.

Clinical significance[edit | edit source]

Alterations in the function or expression of IFNK can have significant clinical implications. For example, reduced levels of IFNK have been associated with increased susceptibility to viral infections. Conversely, overexpression of IFNK can lead to chronic inflammation and autoimmune diseases.

Research[edit | edit source]

Research into IFNK is ongoing, with studies investigating its role in various diseases and its potential as a therapeutic target. For example, IFNK has been implicated in the pathogenesis of diseases such as multiple sclerosis and lupus. In addition, there is interest in harnessing the antiviral and immune-stimulating properties of IFNK for the treatment of viral infections and cancer.